Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-XACP3
- Development stage
- Preclinical
- Lead developer
- The First Hospital of Fujian Medical University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals
- Administration
- Intravenous
01
Overview
68Ga-XACP3 is a gallium-68 labeled radiopharmaceutical designed for positron emission tomography (PET) imaging. It specifically targets Prostatic Acid Phosphatase (ACP3), also known as Prostatic Acid Phosphatase (PAP), an enzyme that is highly expressed in prostate cancer tissue. As a diagnostic agent, 68Ga-XACP3 is intended to detect primary tumor lesions, metastases, and recurrences in patients with prostate cancer. It is being evaluated as an alternative or complement to PSMA-targeted PET imaging (such as 68Ga-PSMA), potentially offering diagnostic utility in cases where PSMA expression is low or absent.
- Other names
- gallium Ga 68 XACP368Ga-labeled XACP3
02
Targets
PAP (Prostatic acid phosphatase)
Beyond the preview
Go deeper on 68Ga-XACP3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-XACP3.